Quiroga: Vaccines bought by Brazil ‘have no power to control’ monkeypox outbreak – News

The Minister of Health, Marcelo Quiroga, said on Monday (22) that Brazil bought 50,000 doses of monkeypox vaccine (monkeypox) “You don’t have the power to control this outbreak” in the country.

The quantity was obtained from the Danish North Bavarian laboratory, through the Revolving Fund of the Pan American Health Organization (PAHO), and is supposed to arrive in Brazil in September. Each person receives two doses, which means that 25,000 Brazilians can be immunized.

“These vaccines are in place to protect health professionals who come into direct contact with contaminated materials,” the minister said at a press conference.

According to Quiroga, there is no need to vaccinate all health professionals because “the vast majority of them do not deal with this situation.”

The minister also rejected the need for mass immunization against monkeypox at the present time, saying that the epidemiological scenario does not point in this direction.

The representative of the Pan American Health Organization in Brazil, Socorro Gros, who attended the press conference, added that the immune system that is being used globally as a tool to counter the progression of monkeypox was developed for human smallpox, a disease that has already been eradicated.

For this reason, no efficacy tests have been performed, but it is a safe vaccine.

“The importance of this now is that countries using the vaccine are working to develop evidence to determine how effective this vaccine is. [doença]It is of the orthopoxvirus family, but it is different. “

There are indications that the Nordic Bavarian vaccine may provide a degree of protection against monkeypox. But it is not yet known how effective and how long immunity lasts.

The main precautionary measure to protect against monkeypox virus infection is to avoid skin contact, especially in infected persons with skin lesions.

In addition, Sokoro Grosso says, immediate diagnosis and isolation of confirmed cases are essential.

Recently, the Director-General of the World Health Organization (WHO), Tedros Adhanom, said that stocks of the North Bavarian vaccine are limited, at about 16 million doses, many of which are not even bottled.

The Brazilian government is trying to get more doses, but the fact that the company does not have a representative in the country is an obstacle, as all negotiations must be done through the PAHO.

On Friday (19), Anvisa (the National Health Surveillance Agency) facilitated the arrival of the fortified people to Brazil, Cancellation of the registration requirement for this as well as for medicines Used in the treatment of acute monkeypox patients.

In recent days, Brazil has become the third country in the world in terms of the number of confirmed cases of monkeypox virus, with 3,788 notifications as of Sunday (21).

It is followed by the United States (14,595) and Spain (6,192).

I have monkeypox symptoms. What should I do? Clear this and other doubts